{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:25:30Z","timestamp":1780046730883,"version":"3.53.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science London","doi-asserted-by":"publisher","award":["JP21K09702"],"award-info":[{"award-number":["JP21K09702"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00417-025-06945-z","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T07:36:08Z","timestamp":1756107368000},"page":"3121-3129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Six-month outcomes of half-fluence photodynamic therapy combined with intravitreal Aflibercept injection for pachychoroid neovasculopathy"],"prefix":"10.1007","volume":"263","author":[{"given":"Yosuke","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4662-9755","authenticated-orcid":false,"given":"Satomi","family":"Shiose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Notomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keijiro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-Hei","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"6945_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/iae.0000000000000331","volume":"35","author":"CE Pang","year":"2015","unstructured":"Pang CE, Freund KB (2015) Pachychoroid neovasculopathy. Retina 35:1\u20139. https:\/\/doi.org\/10.1097\/iae.0000000000000331","journal-title":"Retina"},{"key":"6945_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10384-020-00740-5","volume":"64","author":"Y Yanagi","year":"2020","unstructured":"Yanagi Y (2020) Pachychoroid disease: a new perspective on exudative maculopathy. Jpn J Ophthalmol 64:323\u2013337. https:\/\/doi.org\/10.1007\/s10384-020-00740-5","journal-title":"Jpn J Ophthalmol"},{"key":"6945_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","volume":"33","author":"CMG Cheung","year":"2019","unstructured":"Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB (2019) Pachychoroid disease. Eye (Lond) 33:14\u201333. https:\/\/doi.org\/10.1038\/s41433-018-0158-4","journal-title":"Eye (Lond)"},{"key":"6945_CR4","doi-asserted-by":"publisher","first-page":"19903","DOI":"10.1038\/s41598-023-47325-z","volume":"13","author":"H Matsumoto","year":"2023","unstructured":"Matsumoto H, Hoshino J, Nakamura K, Kishi S, Akiyama H (2023) Attenuation of irradiated choroid and its regional vortex veins in central serous chorioretinopathy after photodynamic therapy. Sci Rep 13:19903. https:\/\/doi.org\/10.1038\/s41598-023-47325-z","journal-title":"Sci Rep"},{"key":"6945_CR5","doi-asserted-by":"publisher","first-page":"e18441","DOI":"10.1016\/j.heliyon.2023.e18441","volume":"9","author":"T Kogo","year":"2023","unstructured":"Kogo T, Muraoka Y, Ishikura M, Nishigori N, Ueda-Arakawa N, Miyata M, Tamura H, Hata M, Takahashi A, Miyake M, Tsujikawa A (2023) Widefield choroidal vasculature associated with future condition of subretinal fluid in central serous chorioretinopathy. Heliyon 9:e18441. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18441","journal-title":"Heliyon"},{"key":"6945_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ophtha.2012.07.042","volume":"120","author":"GS Ying","year":"2013","unstructured":"Ying GS, Huang J, Maguire MG, Jaffe GJ, Grunwald JE, Toth C, Daniel E, Klein M, Pieramici D, Wells J, Martin DF (2013) Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. Ophthalmology 120:122\u2013129. https:\/\/doi.org\/10.1016\/j.ophtha.2012.07.042","journal-title":"Ophthalmology"},{"key":"6945_CR7","doi-asserted-by":"publisher","unstructured":"Maguire MG, Martin DF, Ying GS, Jaffe GJ, Daniel E, Grunwald JE, Toth CA, Ferris FL 3rd, Fine SL (2016) Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials. Ophthalmology 123:1751\u20131761. https:\/\/doi.org\/10.1016\/j.ophtha.2016.03.045","DOI":"10.1016\/j.ophtha.2016.03.045"},{"key":"6945_CR8","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1007\/s00417-024-06582-y","volume":"262","author":"Y Fukuda","year":"2024","unstructured":"Fukuda Y, Notomi S, Shiose S, Maehara Y, Kiyohara K, Fujiwara K, Hashimoto S, Kano K, Ishikawa K, Hisatomi T, Sonoda KH (2024) Three-month outcomes of treatment with faricimab or aflibercept for neovascular age-related macular degeneration: a propensity score matching study in a Japanese population. Graefes Arch Clin Exp Ophthalmol 262:3971\u20133978. https:\/\/doi.org\/10.1007\/s00417-024-06582-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"6945_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s10384-018-0562-0","volume":"62","author":"H Matsumoto","year":"2018","unstructured":"Matsumoto H, Hiroe T, Morimoto M, Mimura K, Ito A, Akiyama H (2018) Efficacy of treat-and-extend regimen with Aflibercept for pachychoroid neovasculopathy and type 1 neovascular age-related macular degeneration. Jpn J Ophthalmol 62:144\u2013150. https:\/\/doi.org\/10.1007\/s10384-018-0562-0","journal-title":"Jpn J Ophthalmol"},{"key":"6945_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12886-021-02022-1","volume":"21","author":"B Schworm","year":"2021","unstructured":"Schworm B, Luft N, Keidel LF, Kreutzer TC, Herold TR, Priglinger SG, Siedlecki J (2021) Vanishing pachy-choroid in pachychoroid neovasculopathy under long-term anti-vascular endothelial growth factor therapy. BMC Ophthalmol 21:269. https:\/\/doi.org\/10.1186\/s12886-021-02022-1","journal-title":"BMC Ophthalmol"},{"key":"6945_CR11","doi-asserted-by":"crossref","unstructured":"(1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials\u2013TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Arch Ophthalmol 117: 1329\u20131345","DOI":"10.1001\/archopht.117.10.1329"},{"key":"6945_CR12","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.ophtha.2010.01.023","volume":"117","author":"I Maruko","year":"2010","unstructured":"Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, Spaide RF (2010) Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 117:1792\u20131799. https:\/\/doi.org\/10.1016\/j.ophtha.2010.01.023","journal-title":"Ophthalmology"},{"key":"6945_CR13","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s00417-020-04661-4","volume":"258","author":"Y Kitajima","year":"2020","unstructured":"Kitajima Y, Maruyama-Inoue M, Ito A, Sato S, Inoue T, Yamane S, Kadonosono K (2020) One-year outcome of combination therapy with intravitreal anti-vascular endothelial growth factor and photodynamic therapy in patients with pachychoroid neovasculopathy. Graefes Arch Clin Exp Ophthalmol 258:1279\u20131285. https:\/\/doi.org\/10.1007\/s00417-020-04661-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"6945_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10384-023-00978-9","volume":"67","author":"N Yamada-Okahara","year":"2023","unstructured":"Yamada-Okahara N, Kyo A, Hirayama K, Yamamoto M, Kohno T, Honda S (2023) Practical treatment options for persistent central serous chorioretinopathy and early visual and anatomical outcomes. Jpn J Ophthalmol 67:295\u2013300. https:\/\/doi.org\/10.1007\/s10384-023-00978-9","journal-title":"Jpn J Ophthalmol"},{"key":"6945_CR15","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","volume":"135","author":"A Koh","year":"2017","unstructured":"Koh A, Lai TYY, Takahashi K, Wong TY, Chen LJ, Ruamviboonsuk P, Tan CS, Feller C, Margaron P, Lim TH, Lee WK (2017) Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial. JAMA Ophthalmol 135:1206\u20131213. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.4030","journal-title":"JAMA Ophthalmol"},{"key":"6945_CR16","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.4103\/ijo.IJO_1481_18","volume":"67","author":"R Roy","year":"2019","unstructured":"Roy R, Saurabh K, Shah D, Goel S (2019) Treatment outcomes of pachychoroid neovasculopathy with photodynamic therapy and anti-vascular endothelial growth factor. Indian J Ophthalmol 67:1678\u20131683. https:\/\/doi.org\/10.4103\/ijo.IJO_1481_18","journal-title":"Indian J Ophthalmol"},{"key":"6945_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13061608","author":"Y Fukuda","year":"2024","unstructured":"Fukuda Y, Notomi S, Shiose S, Maehara Y, Kiyohara K, Hashimoto S, Kano K, Ishikawa K, Hisatomi T, Sonoda KH (2024) Wide-field choroidal thickness analysis after half-fluence photodynamic therapy combined with intravitreal aflibercept injection in pachychoroid neovasculopathy. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13061608","journal-title":"J Clin Med"},{"key":"6945_CR18","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1007\/s00417-023-06030-3","volume":"261","author":"J Takeuchi","year":"2023","unstructured":"Takeuchi J, Ota H, Nakano Y, Horiguchi E, Taki Y, Ito Y, Terasaki H, Nishiguchi KM, Kataoka K (2023) Predictive factors for outcomes of half-dose photodynamic therapy combined with Aflibercept for pachychoroid neovasculopathy. Graefes Arch Clin Exp Ophthalmol 261:2235\u20132243. https:\/\/doi.org\/10.1007\/s00417-023-06030-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"6945_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ph15040483","author":"M Sato-Akushichi","year":"2022","unstructured":"Sato-Akushichi M, Ono S, Taneda T, Klose G, Sasamori A, Song Y (2022) One-year outcome of combination therapy with full or reduced photodynamic therapy and one anti-vascular endothelial growth factor in pachychoroid neovasculopathy. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph15040483","journal-title":"Pharmaceuticals (Basel)"},{"key":"6945_CR20","doi-asserted-by":"publisher","first-page":"e0248760","DOI":"10.1371\/journal.pone.0248760","volume":"16","author":"A Miki","year":"2021","unstructured":"Miki A, Kusuhara S, Otsuji T, Kawashima Y, Miki K, Imai H, Nakamura M, Tsujikawa A (2021) Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy. PLoS One 16:e0248760. https:\/\/doi.org\/10.1371\/journal.pone.0248760","journal-title":"PLoS One"},{"key":"6945_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2147\/opth.S345403","volume":"16","author":"K Takahashi","year":"2022","unstructured":"Takahashi K, Iida T, Ishida S, Crawford B, Sakai Y, Mochizuki A, Tsujiuchi R, Tanaka S, Imai K (2022) Effectiveness of current treatments for wet age-related macular degeneration in Japan: a systematic review and pooled data analysis. Clin Ophthalmol 16:531\u2013540. https:\/\/doi.org\/10.2147\/opth.S345403","journal-title":"Clin Ophthalmol"},{"key":"6945_CR22","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s00417-024-06387-z","volume":"262","author":"N Tanaka","year":"2024","unstructured":"Tanaka N, Azuma K, Aoki S, Kitamoto K, Ueda K, Fujino R, Inoue T, Obata R (2024) Intravitreal anti-vascular endothelial growth factor and combined photodynamic therapy for pachychoroid neovasculopathy: long-term treatment outcomes. Graefes Arch Clin Exp Ophthalmol 262:1811\u20131818. https:\/\/doi.org\/10.1007\/s00417-024-06387-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"6945_CR23","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/iae.0000000000000809","volume":"36","author":"JH Lee","year":"2016","unstructured":"Lee JH, Lee WK, ONE-YEAR RESULTS OF ADJUNCTIVE PHOTODYNAMIC THERAPY FOR TYPE 1 NEOVASCULARIZATION ASSOCIATED WITH THICKENED CHOROID (2016) Retina 36:889\u2013895. https:\/\/doi.org\/10.1097\/iae.0000000000000809","journal-title":"Retina"},{"key":"6945_CR24","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1167\/iovs.02-1115","volume":"44","author":"U Schmidt-Erfurth","year":"2003","unstructured":"Schmidt-Erfurth U, Schl\u00f6tzer-Schrehard U, Cursiefen C, Michels S, Beckendorf A, Naumann GO (2003) Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 44:4473\u20134480. https:\/\/doi.org\/10.1167\/iovs.02-1115","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6945_CR25","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.2147\/opth.S135461","volume":"11","author":"MG Asahi","year":"2017","unstructured":"Asahi MG, Chon AT, Gallemore E, Gallemore RP (2017) Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy. Clin Ophthalmol 11:2051\u20132056. https:\/\/doi.org\/10.2147\/opth.S135461","journal-title":"Clin Ophthalmol"},{"key":"6945_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10384-020-00722-7","volume":"64","author":"H Matsumoto","year":"2020","unstructured":"Matsumoto H, Mukai R, Kikuchi Y, Morimoto M, Akiyama H (2020) One-year outcomes of half-fluence photodynamic therapy combined with intravitreal injection of Aflibercept for pachychoroid neovasculopathy without polypoidal lesions. Jpn J Ophthalmol 64:203\u2013209. https:\/\/doi.org\/10.1007\/s10384-020-00722-7","journal-title":"Jpn J Ophthalmol"},{"key":"6945_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10384-023-00981-0","volume":"67","author":"T Sawada","year":"2023","unstructured":"Sawada T, Yasukawa T, Imaizumi H, Matsubara H, Kimura K, Terasaki H, Ishikawa H, Murakami T, Takeuchi M, Mitamura Y, Mizusawa Y, Takamura Y, Murata T, Kogo J, Ohji M (2023) Subtype prevalence and baseline visual acuity by age in Japanese patients with neovascular age-related macular degeneration. Jpn J Ophthalmol 67:149\u2013155. https:\/\/doi.org\/10.1007\/s10384-023-00981-0","journal-title":"Jpn J Ophthalmol"},{"key":"6945_CR28","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1097\/iae.0000000000001873","volume":"38","author":"R Sacconi","year":"2018","unstructured":"Sacconi R, Corbelli E, Carnevali A, Querques L, Bandello F, Querques G (2018) Optical coherence tomography angiography in geographic atrophy. Retina 38:2350\u20132355. https:\/\/doi.org\/10.1097\/iae.0000000000001873","journal-title":"Retina"},{"key":"6945_CR29","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1167\/iovs.19-27100","volume":"60","author":"M Nassisi","year":"2019","unstructured":"Nassisi M, Mohand-Sa\u00efd S, Andrieu C, Antonio A, Condroyer C, M\u00e9j\u00e9case C, Dhaenens CM, Sahel JA, Zeitz C, Audo I (2019) Peripapillary sparing with near infrared autofluorescence correlates with electroretinographic findings in patients with Stargardt disease. Invest Ophthalmol Vis Sci 60:4951\u20134957. https:\/\/doi.org\/10.1167\/iovs.19-27100","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6945_CR30","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s10384-022-00910-7","volume":"66","author":"Y Fukuda","year":"2022","unstructured":"Fukuda Y, Nakao S, Kohno RI, Ishikawa K, Shimokawa S, Shiose S, Takeda A, Morizane Y, Sonoda KH (2022) Postoperative follow-up of submacular hemorrhage displacement treated with vitrectomy and subretinal injection of tissue plasminogen activator: ultrawide-field fundus autofluorescence imaging in gas-filled eyes. Jpn J Ophthalmol 66:264\u2013270. https:\/\/doi.org\/10.1007\/s10384-022-00910-7","journal-title":"Jpn J Ophthalmol"},{"key":"6945_CR31","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1073\/pnas.0630280100","volume":"100","author":"NM Haralampus-Grynaviski","year":"2003","unstructured":"Haralampus-Grynaviski NM, Lamb LE, Clancy CM, Skumatz C, Burke JM, Sarna T, Simon JD (2003) Spectroscopic and morphological studies of human retinal lipofuscin granules. Proc Natl Acad Sci U S A 100:3179\u20133184. https:\/\/doi.org\/10.1073\/pnas.0630280100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6945_CR32","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.ophtha.2005.01.003","volume":"112","author":"RF Spaide","year":"2005","unstructured":"Spaide RF, Klancnik JM Jr (2005) Fundus autofluorescence and central serous chorioretinopathy. Ophthalmology 112:825\u2013833. https:\/\/doi.org\/10.1016\/j.ophtha.2005.01.003","journal-title":"Ophthalmology"},{"key":"6945_CR33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ajo.2010.09.031","volume":"151","author":"H Matsumoto","year":"2011","unstructured":"Matsumoto H, Kishi S, Sato T, Mukai R (2011) Fundus autofluorescence of elongated photoreceptor outer segments in central serous chorioretinopathy. Am J Ophthalmol 151:617\u2013623e611. https:\/\/doi.org\/10.1016\/j.ajo.2010.09.031","journal-title":"Am J Ophthalmol"},{"key":"6945_CR34","doi-asserted-by":"publisher","first-page":"e0282057","DOI":"10.1371\/journal.pone.0282057","volume":"18","author":"R Funatsu","year":"2023","unstructured":"Funatsu R, Sonoda S, Terasaki H, Shiihara H, Mihara N, Horie J, Sakamoto T (2023) Effect of photodynamic therapy on choroid of the medial area from optic disc in patients with central serous chorioretinopathy. PLoS One 18:e0282057. https:\/\/doi.org\/10.1371\/journal.pone.0282057","journal-title":"PLoS One"},{"key":"6945_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12165364","author":"Y Fukuda","year":"2023","unstructured":"Fukuda Y, Notomi S, Shiose S, Kano K, Hashimoto S, Fujiwara K, Akiyama M, Ishikawa K, Hisatomi T, Sonoda KH (2023) Differences in central and peripheral choroidal thickness among the subtypes of age-related macular degeneration in an Asian population. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12165364","journal-title":"J Clin Med"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06945-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06945-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06945-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T03:51:00Z","timestamp":1764820260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06945-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["6945"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06945-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board at Kyushu University, Fukuoka, Japan (REB #26\u2013131) and adhered to the tenets of the Declaration of Helsinki. Written informed consent was obtained from all participants involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}